DARGLITAZONE
UNII AVP9C03Z3K

Substance Identification & Data

This profile provides standardized clinical and technical data for Darglitazone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AVP9C03Z3K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 141200-24-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AVP9C03Z3K

CAS Registry Number

141200-24-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DARGLITAZONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H20N2O4S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QQKNSPHAFATFNQ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75187

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

60870

Unique identification number in the NCBI database of chemical substances.

INN ID

7092

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S1C(NC(C1Cc2ccc(cc2)C(CCc3nc(oc3C)-c4ccccc4)=O)=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Darglitazone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.